Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Correlation Between Par-4 and Telomere-telomerase System in the New Dignosised Type 2 Diabetes Patients Who Received GLP-1 Analog or Metformin Treatment

NCT02535299 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT02535299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02535299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Correlation Between Par-4 and Telomere-telomerase System in the New Dignosised Type 2 Diabetes Patients Who Received GLP-1 Analog or Metformin Treatment
Lead sponsor
Third Military Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2019
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glp-1；metformin；telomere-telomerase system；par-4